Skip to content
Trial Eligibility
Menu

The Effect of PROSE or Scleral Lenses on Mental Health

NCT07195721

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this prospective clinical trial is to evaluate the effect that prosthetic replacement of the ocular surface ecosystem (PROSE, BostonSight, Needham MA) treatment may have on mental health, particularly affective mood disorders. Correlation between changes in mental health and ocular symptom improvement and/or visual function improvement will be evaluated.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Depression - Major Depressive Disorder

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
Any age
Sex
All
Healthy volunteers
Not accepted
Sponsor
Boston Sight
Last updated on ClinicalTrials.gov
January 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • BostonSight · Needham, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.